VILITRA

What Is Vilitra?

Vilitra is a brand of generic vardenafil hydrochloride produced by Centurion Laboratories Pvt. Ltd., a Gujarat-based Indian pharmaceutical company operating under WHO-GMP (Good Manufacturing Practices) certification with export licenses covering more than 30 countries. Centurion Laboratories is best known for producing high-quality generic ED treatments that replicate the therapeutic performance of branded originals while making them accessible at realistic prices for everyday consumers.

The active ingredient, vardenafil hydrochloride, is the same molecule found in branded Levitra — the ED medication developed by Bayer Pharmaceuticals and GlaxoSmithKline and first approved by the U.S. FDA in 2003. Levitra was the second oral PDE5 inhibitor to receive FDA approval after Viagra, and it was developed with a specific focus on producing a more selective, more potent compound with a cleaner side effect profile than sildenafil.

Since Bayer's U.S. exclusivity on vardenafil expired in 2018, high-quality generics like Vilitra have made this superior molecule available at a fraction of Levitra's branded price — preserving all the clinical benefits of vardenafil while removing the cost barrier that previously kept many men from accessing it. Vilitra is available in six distinct formulations spanning doses from 10 mg to 80 mg, plus the Super Vilitra dual-action combination — giving men a level of dosing flexibility that branded Levitra never offered.

Vardenafil's Unique Pharmacological Profile: Why It's Different from Sildenafil

Most men looking at ED medications encounter a lot of content that treats sildenafil, vardenafil, and tadalafil as essentially interchangeable — "they all do the same thing." This is an oversimplification that misses clinically significant differences. Vardenafil, in particular, has a distinct molecular profile that explains why it is the preferred choice for specific patient populations and why many men who switch to it from sildenafil do not go back.

Greater Potency Per Milligram

Vardenafil has an IC50 value for PDE5 inhibition of approximately 0.4 nM — compared to sildenafil's 4 nM. IC50 is the concentration required to inhibit 50% of enzyme activity; a lower number means the drug is more potent. This means vardenafil achieves the same degree of PDE5 inhibition at a roughly 10-fold lower molecular concentration than sildenafil. In practical terms, this translates to effective results at lower milligram doses relative to sildenafil — which is why Vilitra 10 mg or 20 mg often produces results comparable to sildenafil 50 mg or 100 mg.

Superior PDE5 vs PDE6 Selectivity — Fewer Visual Side Effects

PDE6 is an enzyme found in the photoreceptor cells of the retina. It plays a critical role in phototransduction — the conversion of light into visual nerve signals. When a PDE5 inhibitor inhibits PDE6 as a secondary off-target effect, it can cause transient visual disturbances including blurred vision, increased light sensitivity, and the characteristic blue-green color tint (cyanopsia) reported by some sildenafil users.

Vardenafil has a higher selectivity ratio for PDE5 over PDE6 than sildenafil. This means it is less likely to inhibit the retinal PDE6 enzyme at therapeutic doses, resulting in a meaningfully lower incidence of visual side effects — a clinically relevant advantage for men who have experienced visual disturbances with sildenafil or who have underlying retinal health concerns.

PDE5 Selectivity Comparison Across the Main ED Molecules

This pharmacological distinction is not just a technical footnote — it directly explains why a meaningful proportion of men who switch from sildenafil to vardenafil report a cleaner, more comfortable experience, with fewer side effects and equal or superior therapeutic outcomes.

Proven Efficacy in High-Difficulty Populations

Multiple randomized controlled trials have demonstrated that vardenafil achieves strong ED treatment outcomes — typically 70–85% successful intercourse attempts — across a broad range of patient populations, including men with type 1 and type 2 diabetes, men with hypertension, men who are post-radical prostatectomy, and men who have not responded adequately to sildenafil. Diabetic men with ED — a particularly challenging population because vascular and neurological damage compounds the pharmacological barrier — show consistently strong outcomes with vardenafil across the clinical literature.

How Vilitra Works: The Mechanism of Action

Vilitra works through selective inhibition of the PDE5 enzyme in the smooth muscle cells of the penile corpus cavernosum. Here's a step-by-step breakdown of the complete pathway:

Step 1 — Arousal Triggers Nitric Oxide Release

Sexual stimulation activates the non-adrenergic non-cholinergic (NANC) neurons in the cavernous tissue of the penis, triggering the release of nitric oxide (NO). Nitric oxide then activates the enzyme guanylate cyclase, which converts GTP into cyclic guanosine monophosphate (cGMP). This cGMP molecule is the central vasodilatory signal in the erection process.

Step 2 — cGMP Relaxes Smooth Muscle and Enables Blood Flow

Rising cGMP levels in the smooth muscle cells of the corpus cavernosum cause those cells to relax. The penile arterioles dilate, intracavernous pressure rises, sinusoidal spaces fill with blood, and the tunica albuginea — the tough outer membrane of the corpus cavernosum — traps this blood under pressure, producing a rigid, sustained erection.

Step 3 — PDE5 Breaks Down cGMP (The Problem in ED)

In men with erectile dysfunction — whether from vascular disease, diabetes, neurological damage, or age-related changes — the PDE5 enzyme degrades cGMP faster than the body can replenish it, preventing the vasodilation threshold needed for a satisfactory erection from being reached or sustained.

Step 4 — Vardenafil Inhibits PDE5 and Restores Function

Vardenafil binds selectively to the catalytic site of the PDE5 enzyme with high affinity (IC50 ≈ 0.4 nM), blocking its cGMP-degrading activity. With PDE5 inhibited, cGMP accumulates to levels sufficient for robust smooth muscle relaxation and blood flow. Sexual stimulation remains essential — vardenafil does not create erections independently. It amplifies and sustains the physiological response to arousal that the disease process was suppressing.

Onset of action for Vilitra standard tablets is typically 25 to 60 minutes after ingestion, with peak plasma concentration reached at approximately 60 minutes. The therapeutic window lasts 4 to 6 hours in most men — slightly longer than sildenafil's typical 4-hour window, providing more flexibility for natural, unhurried intimacy.

The Complete Vilitra Range: Every Dose, Every Need

Vilitra stands apart from most vardenafil brands by offering one of the widest dose ranges of any single generic ED product family. From the conservative 10 mg entry point to the maximum-strength 80 mg, and including the clinically unique dual-action Super Vilitra, there is a formulation for every man's situation.

Quick-reference overview of all Vilitra formulations we carry:

Vilitra 10 mg — The Careful Starting Point

Vilitra 10 mg is the lowest dose in the range and the ideal starting point for men who are new to vardenafil, are older (65+), have mild ED, or are on medications that may interact with PDE5 inhibitors. Starting low and adjusting upward based on response and tolerability is the recommended clinical approach — and the 10 mg dose allows this calibration to happen safely.

It's also the right choice for men who have experienced significant side effects with 50 mg or 100 mg sildenafil and want to explore whether vardenafil's greater potency per milligram delivers satisfactory results at a lower absolute dose. Our Vilitra 10 mg tablets are priced accessibly and represent the cleanest, lowest-risk entry into vardenafil treatment.

Vilitra 20 mg — The Standard Vardenafil Dose

Vilitra 20 mg is the benchmark dose for vardenafil treatment — equivalent to the standard prescribed dose of branded Levitra — and the most widely used strength in the Vilitra range. For most men with mild to moderate ED who have no significant comorbidities and are not on interacting medications, 20 mg delivers optimal efficacy with a well-established side effect profile.

Clinical studies at the 20 mg dose consistently report 75–80% successful intercourse rates, including in men with diabetes and hypertension. Our Vilitra 20 mg is the natural first choice for most men trying vardenafil for the first time, and the most consistently reordered dose in our Vilitra lineup.

Vilitra 40 mg — Stepping Up for Greater Response

Vilitra 40 mg is the next step for men who have found 20 mg provides an inadequate or inconsistent response. At 40 mg, vardenafil's PDE5 inhibition is substantially stronger, producing a more reliable, more sustained erection in men with more advanced or treatment-resistant ED. This dose is commonly prescribed for men whose ED is driven by chronic conditions — such as well-established type 2 diabetes or peripheral arterial disease — that reduce baseline vascular responsiveness.

Our Vilitra 40 mg maintains the same pharmaceutical quality and Centurion Labs pedigree as the rest of the range. Dose escalation from 20 mg to 40 mg should be done under physician guidance, particularly for men with cardiovascular disease or those on antihypertensive medications.

Vilitra 60 mg — High-Strength for Severe or Diabetic ED

Vilitra 60 mg is specifically suited to men with severe erectile dysfunction or those whose ED is complicated by conditions that significantly impair vascular and neurological function — most notably diabetes, which both damages penile blood vessels and degrades the autonomic nerve signaling that triggers the NO pathway.

Clinical evidence supports higher-dose vardenafil in diabetic men as a safe and effective approach. The Vilitra 60 mg is also appropriate for men who have stepped up through 20 mg and 40 mg without achieving satisfactory results, or who have been specifically recommended a higher dose by their prescribing physician.

Vilitra 80 mg — Maximum-Strength Vardenafil

Vilitra 80 mg represents the maximum single-dose vardenafil strength available in the range — more than the maximum daily dose of branded Levitra (20 mg) by a factor of four. This high-strength formulation is intended exclusively for men with severe, treatment-resistant erectile dysfunction who have been carefully evaluated by a physician and determined to require maximum PDE5 inhibition for any clinically meaningful response.

At 80 mg, the risk profile of vardenafil — particularly around blood pressure effects, back muscle pain, and cardiovascular considerations — increases meaningfully. Our Vilitra 80 mg is the most powerful option in our vardenafil catalog and is appropriate only for men with physician supervision and confirmed clinical need.

Super Vilitra — Dual-Action: ED + Premature Ejaculation

Super Vilitra is the most clinically sophisticated product in the Vilitra range. Each tablet combines 20 mg vardenafil — for erectile function — with 60 mg dapoxetine — a selective serotonin reuptake inhibitor (SSRI) clinically proven to delay ejaculation and treat premature ejaculation (PE). This makes Super Vilitra a true dual-action formulation that addresses the two most common male sexual dysfunction conditions simultaneously in a single tablet.

Dapoxetine works by inhibiting the reuptake of serotonin in the synapse, extending the serotonin signaling that delays ejaculation. Unlike daily SSRIs prescribed off-label for PE (such as sertraline or paroxetine), dapoxetine has a short half-life of approximately 1.5 hours — making it purpose-designed for on-demand use before sexual activity, without the persistent systemic effects of a long-term SSRI.

For American men dealing with the compounding frustration of both ED and PE — a combination that affects a significant proportion of men with sexual dysfunction — our Super Vilitra is among the most clinically complete single-tablet solutions we carry. Instead of managing two separate conditions with two separate medications, Super Vilitra handles both in one coordinated dose.

Vilitra (Vardenafil) vs. Sildenafil: The Key Clinical Differences

Sildenafil-based treatments dominate the generic ED market in terms of sheer volume — but "most common" does not mean "best for everyone." Vardenafil was specifically developed as a more refined PDE5 inhibitor, and the clinical differences between the two molecules are meaningful for many men.

Potency

Vardenafil is roughly 10 times more potent per milligram at inhibiting PDE5 than sildenafil. A 10 mg dose of vardenafil achieves a degree of PDE5 inhibition that requires approximately 50-100 mg of sildenafil. For men who need less drug to achieve the same therapeutic outcome, vardenafil's superior potency translates to lower absolute doses with potentially fewer systemic side effects.

Visual Side Effects

The blue-green color tint and visual sensitivity changes associated with sildenafil use are caused by off-target PDE6 inhibition in the retina. Vardenafil's higher selectivity for PDE5 over PDE6 results in a significantly lower incidence of visual disturbances than sildenafil — a clinically documented difference that is particularly important for men with existing retinal or visual health concerns. Our Cenforce range and other sildenafil generics remain excellent choices for men who tolerate sildenafil well; but for those troubled by visual side effects, Vilitra is the superior molecular choice.

Onset

Vardenafil's onset of action is generally slightly faster than sildenafil — some studies report clinically meaningful erections beginning as early as 10 to 25 minutes after ingestion in responsive patients, compared to sildenafil's typical 30-45 minute onset. This modest advantage adds a degree of spontaneity that some men find clinically meaningful.

Diabetic Men

Multiple head-to-head clinical trials have demonstrated that vardenafil achieves superior efficacy in men with diabetes-related ED compared to equivalent sildenafil doses. The reasons are mechanistic: vardenafil's greater potency means it achieves effective PDE5 inhibition even in the presence of the reduced nitric oxide availability and impaired smooth muscle signaling that characterize diabetic vascular disease. For men whose ED is primarily driven by diabetic complications, Vilitra is frequently the better clinical choice.

Vilitra vs. Other Vardenafil Brands We Carry

Our store carries the full range of vardenafil generics from multiple manufacturers. Here's how Vilitra compares to our other vardenafil brands:

Vilitra vs. Snovitra

Snovitra is RSM Multilink's vardenafil brand, available in doses from 20 mg to 120 mg — making it the highest-ceiling vardenafil brand we carry. For men who require doses beyond 80 mg under physician supervision, Snovitra's Super Snovitra and high-dose variants fill a niche that Vilitra's 80 mg ceiling does not reach. Our Snovitra range is the natural next step for men who have reached the top of the Vilitra dose ladder and still require escalation.

Vilitra vs. Carevitra

Carevitra is our own-branded vardenafil formulation, designed to deliver pharmaceutical-grade vardenafil at our most competitive price point. For men looking for no-frills effective vardenafil treatment at maximum affordability, our Carevitra range is the value-focused alternative within our vardenafil lineup. Vilitra, as a Centurion Laboratories product with broader international recognition, tends to be the preferred choice for men who place weight on manufacturer reputation and established brand heritage.

Vilitra vs. Tadalafil (Tadaflo, Vidalista, etc.)

The primary decision between vardenafil and tadalafil comes down to duration and lifestyle fit. Vardenafil offers a 4-to-6-hour active window with faster onset — ideal for men who want reliable on-demand performance. Tadalafil offers up to 36 hours with a daily-dosing option — ideal for men who prefer not to plan around medication timing. Neither molecule is clinically superior across all populations; the right choice depends on lifestyle, comorbidities, and personal preference. Explore our complete Tadalafil range for the full comparison of tadalafil options we carry.

Vilitra Dosage and How to Take It Correctly

Recommended Starting Dose

For most adult men new to vardenafil, the recommended starting dose is Vilitra 20 mg — the equivalent of the standard branded Levitra starting dose. Your physician may recommend beginning at 10 mg if you are older, have significant cardiovascular risk factors, or are on medications known to interact with PDE5 inhibitors. Dose can be adjusted upward to 40 mg, 60 mg, or 80 mg based on response and tolerability, always under medical guidance.

When and How to Take Vilitra

Take Vilitra orally with a full glass of water approximately 30 to 60 minutes before planned sexual activity. Swallow the tablet whole — do not crush or chew unless your specific formulation is designed for chewing. Take one dose per 24-hour period only. Vilitra works best on an empty stomach or with a light, low-fat meal. High-fat meals do not block vardenafil's absorption entirely, but they can delay peak plasma concentration by 30-45 minutes — reducing its onset speed advantage.

Grapefruit Interaction — Important

Grapefruit and grapefruit juice contain furanocoumarins that inhibit CYP3A4 — the primary liver enzyme responsible for metabolizing vardenafil. Consuming grapefruit products within 24 hours of taking Vilitra can significantly elevate plasma vardenafil levels, disproportionately amplifying both its effects and its side effects. Avoid grapefruit entirely on the day you plan to take Vilitra.

Alcohol

Moderate alcohol (1-2 drinks) has minimal clinically significant interaction with vardenafil for most men. However, heavier drinking amplifies the blood pressure-lowering effect of vardenafil — increasing the risk of symptomatic hypotension — and directly impairs the central nervous system arousal signaling that vardenafil depends on to work. For best results, keep alcohol consumption to a minimum on the day of use.

Arousal Is Non-Negotiable

Vilitra amplifies the physiological erection response — it does not initiate it. Sexual stimulation must be present for the mechanism to activate. Men who take Vilitra and engage in no sexual stimulation should not expect an erection response. This is a feature of all PDE5 inhibitors, not a limitation of Vilitra specifically.

Vilitra Side Effects: What to Expect and When to Act

Vardenafil's side effect profile is well-characterized across decades of clinical use and is broadly comparable to other PDE5 inhibitors, with the notable advantage of a lower incidence of visual disturbances. Most side effects are mild, dose-dependent, and self-resolving.

Common Side Effects (Mild and Temporary)

• Headache — the most frequently reported vardenafil side effect, typically mild. Caused by cerebral vasodilation. Responsive to over-the-counter analgesics. Tends to diminish with continued use as the body adjusts.
• Facial flushing — warmth or visible redness of the face, neck, and chest. A direct consequence of systemic vasodilation. Harmless and temporary.
• Nasal congestion — mild stuffiness from dilation of nasal mucosal blood vessels. Self-resolving.
• Dizziness or lightheadedness — particularly when changing position suddenly. Most common in older men or those on antihypertensive medications. Rise slowly from sitting or lying positions.
• Indigestion or heartburn — mild gastric discomfort, less common with vardenafil than with sildenafil. Reduced by taking with a light meal.
• Back pain — more associated with tadalafil than vardenafil but occasionally reported. Typically mild and resolves within 48 hours.
• Visual disturbances — significantly less common with vardenafil than with sildenafil due to its superior PDE5/PDE6 selectivity. May occasionally include mild blurring; color tint changes (cyanopsia) are rare at therapeutic vardenafil doses.

Serious Side Effects — Seek Emergency Medical Care Immediately

• Priapism — a prolonged, painful erection lasting more than 4 hours without sexual stimulation. A urological emergency requiring immediate intervention. Without treatment within 4-6 hours, permanent penile tissue damage and irreversible ED may result. Go to an emergency room without delay.
• Sudden vision loss — particularly unilateral (one eye). Possible indicator of NAION (non-arteritic anterior ischemic optic neuropathy). Stop use immediately and seek emergency ophthalmological evaluation.
• Sudden hearing loss or severe tinnitus — abrupt reduction in hearing capacity or severe ringing in the ears. Discontinue use immediately.
• Severe hypotension — especially in men taking nitrates or alpha-blockers concurrently. Can cause fainting, stroke, or cardiac event. The vardenafil-nitrate interaction is absolutely contraindicated.
• QTc prolongation — a unique, vardenafil-specific consideration not shared by sildenafil: vardenafil can cause mild prolongation of the cardiac QTc interval at higher doses. Men taking medications that also prolong QTc — including certain antiarrhythmics (quinidine, sotalol, amiodarone), antipsychotics, and some antibiotics (erythromycin, clarithromycin) — should not take vardenafil without explicit cardiological clearance.

For a broader, clinically grounded comparison of which ED medication is most appropriate given your health background, our blog on choosing the best pill for ED covers the complete picture across all four PDE5 inhibitor classes.

Who Should Not Take Vilitra

Vilitra is contraindicated in the following groups. These are not precautions — they are absolute restrictions that must be respected to avoid serious or life-threatening adverse events:

• Men taking any nitrate medication — nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite ("poppers"). The vardenafil-nitrate combination can produce a severe, potentially fatal drop in blood pressure. This is an absolute contraindication with no exceptions.
• Men taking riociguat (Adempas) — used for pulmonary hypertension. All PDE5 inhibitors are absolutely contraindicated with riociguat due to compounding hypotensive effects.
• Men taking QTc-prolonging medications — including class IA/III antiarrhythmics (quinidine, procainamide, amiodarone, sotalol), certain antibiotics (erythromycin, clarithromycin), antifungals (ketoconazole at high doses), and antipsychotics. Combination with vardenafil increases the risk of life-threatening cardiac arrhythmias.
• Men taking potent CYP3A4 inhibitors — ketoconazole 400 mg/day, itraconazole 400 mg/day, ritonavir, indinavir. These dramatically increase vardenafil plasma levels and are contraindicated.
• Men with severe hepatic impairment (Child-Pugh Class C) — significantly impairs vardenafil metabolism, producing dangerously elevated plasma exposure.
• Men with hereditary retinal disorders — including retinitis pigmentosa.
• Men with recent serious cardiovascular events — heart attack, stroke, or life-threatening arrhythmia within the past 6 months; unstable or refractory angina; NYHA Class 3-4 heart failure.
• Men under 18 years of age — vardenafil is not indicated for pediatric use for erectile dysfunction.

Why Erectile Dysfunction Happens — And What It Often Signals

Erectile dysfunction is rarely "just an ED problem." For the majority of men over 40, it is the surface expression of underlying vascular, metabolic, hormonal, or neurological changes that deserve clinical attention beyond simply treating the symptom. Understanding the root cause of your ED is not just medically responsible — it can be the trigger that prompts the early detection of cardiovascular or metabolic disease that would otherwise go undiagnosed for years.

Vascular Disease — The Most Common Physical Cause

The penile arteries are among the smallest arteries in the body — 1 to 2 mm in diameter at the point of entry into the corpus cavernosum. This means they show the effects of atherosclerosis, endothelial dysfunction, and vascular stiffness earlier than the coronary arteries. ED caused by vascular disease is therefore often an early warning sign of the same cardiovascular disease process that may eventually lead to angina or myocardial infarction. Multiple large epidemiological studies have confirmed that men with ED have a significantly elevated risk of cardiac events in the subsequent 5-10 years compared to matched controls without ED.

Diabetes — A Compounding Risk

Up to 75% of men with long-standing diabetes develop erectile dysfunction at some point. Diabetes damages both the penile vasculature (through microvascular disease and oxidative stress) and the autonomic nerves that mediate the NO release pathway (through diabetic neuropathy). This dual mechanism explains why diabetes-related ED tends to be more severe, responds less predictably to standard doses of sildenafil, and is the population for which vardenafil's superior potency and selectivity have the most documented clinical benefit.

Hypertension and Its Medications

Hypertension directly damages arterial endothelium and reduces the nitric oxide bioavailability needed for erection. Compounding this, many antihypertensive medications — particularly older beta-blockers and thiazide diuretics — independently cause ED as a side effect. Men on antihypertensive therapy who develop ED should discuss both their underlying hypertension management and their ED treatment options with their physician.

Psychological and Performance Anxiety-Driven ED

Performance anxiety is the dominant driver of ED in men under 40 and a significant contributing factor at any age. The anticipatory stress of a potential erectile failure activates the sympathetic nervous system — the "fight or flight" response — which directly antagonizes the parasympathetic signaling required for erection. Once the first failure occurs, anxiety about recurrence creates a self-sustaining cycle that becomes increasingly difficult to break without intervention.

Vilitra — particularly at an effective dose — can help break this cycle by providing the physical reliability needed for a man to re-engage sexually without constant anticipatory anxiety. As confidence is rebuilt over multiple successful encounters, the psychological contribution to ED often diminishes significantly. Our blog on how men last longer in bed and build sexual confidence covers the behavioral techniques that complement medication most effectively.

Lifestyle Habits That Maximize Vilitra's Effectiveness

Vardenafil works by amplifying the physiological response to sexual stimulation — which means the stronger and healthier the underlying physiology, the better vardenafil performs. These lifestyle habits directly improve vascular function, hormonal status, and psychological readiness — all of which compound with Vilitra's pharmacological action:

• Sustained aerobic exercise — 150+ minutes of moderate-intensity cardio per week improves endothelial nitric oxide synthase (eNOS) activity — the enzyme responsible for producing the NO that vardenafil's mechanism depends on. The better your NO production, the more cGMP vardenafil has to work with.
• Glycemic control — for diabetic men, maintaining HbA1c below 7.0% preserves nerve function and vascular integrity far better than poorly managed blood sugar, producing meaningfully better PDE5 inhibitor response rates.
• Smoking cessation — nicotine causes acute vasoconstriction and chronic endothelial damage, both of which directly reduce vardenafil's effective ceiling. Quitting at any age improves penile vascular function within weeks.
• Weight management — obesity-related reductions in free testosterone and increases in systemic inflammation both impair PDE5 inhibitor responsiveness. Even modest weight loss (5-10%) in overweight men has been shown to improve erectile function independently.
• Quality sleep (7-9 hours) — testosterone production is predominantly nocturnal. Chronic sleep deprivation reduces circulating testosterone and amplifies cortisol, creating a hormonal environment that undermines sexual function and medication response alike.
• Mental health management — treating depression, reducing chronic anxiety, and addressing relationship conflict are as important to ED outcomes as the medication itself. The psychological component of ED is frequently underestimated and undertreated.

Why American Men Choose ED Care Store for Vilitra

We understand that purchasing ED medication involves trust — in the quality of the product, in the security of the transaction, and in the discretion of the delivery. Here is exactly what we provide:

• Genuine Centurion Laboratories Manufacturing — Every Vilitra product we carry is sourced from Centurion Laboratories' WHO-GMP certified production lines. Quality is non-negotiable.
• The Complete Vilitra Range — All six formulations stocked and ready: 10 mg, 20 mg, 40 mg, 60 mg, 80 mg, and Super Vilitra. You choose what fits your clinical needs.
• Discreet Plain-Outer Packaging — No indication of contents on the exterior of your package. Your health decisions are entirely private.
• Transparent, Competitive Pricing — Compare our Vilitra prices to branded Levitra at a U.S. retail pharmacy. The savings are substantial — often 80-90% less per tablet.
• Nationwide U.S. Delivery with Full Tracking — We ship to all 50 states. Free shipping on qualifying orders over $500.
• 24/7 Customer Support — By call, text, or email. Real people, real answers, whenever you need them.

Vilitra sits within our broader Vardenafil range — which also includes Snovitra and Carevitra for men who want to compare options across all vardenafil manufacturers we carry. For men considering all three PDE5 inhibitor classes, our complete Men's Health collection covers sildenafil, tadalafil, vardenafil, oral jellies, and combination treatments in a single place.

Vilitra FAQ — Straight Answers to the Questions Men Ask Most

Is Vilitra the same as Levitra?

Clinically, yes — Vilitra and Levitra contain the same active molecule (vardenafil hydrochloride) and work through the same pharmacological mechanism. The difference is that Levitra is Bayer's original branded product, while Vilitra is Centurion Laboratories' quality generic manufactured after the patent's expiry. The therapeutic outcome for most men is equivalent; the price is dramatically different.

Why would my doctor suggest vardenafil instead of sildenafil?

Common reasons include: insufficient response to sildenafil at 100 mg, visual side effects with sildenafil, diabetes-related ED where vardenafil's greater potency is clinically advantageous, preference for faster onset, or a physician's assessment that vardenafil's selectivity profile is a better match for the patient's overall health picture. Our blog on penis development and men's sexual health provides useful physiological context for men who want to understand their sexual health more comprehensively.

Can I take Vilitra with blood pressure medication?

It depends on the medication. Alpha-blockers (tamsulosin, doxazosin) and vardenafil together can produce additive hypotension, especially within 6 hours of each other. ACE inhibitors and calcium channel blockers carry a lower interaction risk but should still be discussed with your physician before combining. Beta-blockers generally have a lower hypotensive interaction risk with vardenafil than with sildenafil.

How long does Vilitra 20 mg last?

The average effective window for Vilitra 20 mg is 4 to 6 hours. Individual duration varies based on metabolism rate, age, body weight, presence of food in the stomach, and the degree of underlying ED. Some men experience effects up to 8 hours after ingestion; others find effects begin to wane after 4 hours. The window is slightly longer than sildenafil's typical 4-hour window for most men.

Is Vilitra safe for men with heart conditions?

Vardenafil is safe for most men with stable, well-managed cardiovascular conditions — but the emphasis is on "stable" and "well-managed." Men with unstable angina, recent MI or stroke, severe uncontrolled hypertension, or arrhythmias requiring QTc-prolonging antiarrhythmics are not candidates for vardenafil. Any man with a significant cardiac history should discuss vardenafil specifically — including its unique QTc effect — with their cardiologist before starting treatment.

Medical Disclaimer

The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting, changing, or stopping any medication, including vardenafil. ED Care Store does not diagnose, treat, cure, or prevent any medical condition. All orders are subject to applicable prescription requirements and legal compliance in the purchaser's jurisdiction.